Morgan Stanley’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.15M Sell
432,279
-297,761
-41% -$1.48M ﹤0.01% 4654
2025
Q1
$3.22M Buy
730,040
+399,975
+121% +$1.76M ﹤0.01% 4280
2024
Q4
$1.53M Sell
330,065
-62,182
-16% -$289K ﹤0.01% 4873
2024
Q3
$2.72M Sell
392,247
-629,553
-62% -$4.37M ﹤0.01% 4436
2024
Q2
$7.97M Sell
1,021,800
-484,786
-32% -$3.78M ﹤0.01% 3493
2024
Q1
$10.7M Sell
1,506,586
-3,023,852
-67% -$21.5M ﹤0.01% 3297
2023
Q4
$30.4M Buy
4,530,438
+2,787,779
+160% +$18.7M ﹤0.01% 2963
2023
Q3
$9.81M Buy
1,742,659
+302,177
+21% +$1.7M ﹤0.01% 3146
2023
Q2
$7.95M Sell
1,440,482
-99,901
-6% -$551K ﹤0.01% 3384
2023
Q1
$9.63M Buy
1,540,383
+227,079
+17% +$1.42M ﹤0.01% 3182
2022
Q4
$6.12M Buy
1,313,304
+27,908
+2% +$130K ﹤0.01% 3567
2022
Q3
$6M Sell
1,285,396
-17,572,096
-93% -$82.1M ﹤0.01% 3522
2022
Q2
$112M Buy
18,857,492
+281,300
+2% +$1.67M 0.01% 858
2022
Q1
$359M Buy
18,576,192
+5,687,080
+44% +$110M 0.05% 355
2021
Q4
$421M Buy
12,889,112
+8,184,111
+174% +$267M 0.05% 332
2021
Q3
$193M Buy
4,705,001
+639,551
+16% +$26.2M 0.03% 542
2021
Q2
$146M Buy
4,065,450
+504,944
+14% +$18.2M 0.02% 657
2021
Q1
$139M Buy
3,560,506
+855,772
+32% +$33.4M 0.02% 623
2020
Q4
$109M Buy
2,704,734
+1,054,662
+64% +$42.5M 0.02% 684
2020
Q3
$91.7M Buy
+1,650,072
New +$91.7M 0.02% 622